Adprotech Being Acquired By Inflazyme In C$20M Deal April 14, 2004 By Nuala Moran LONDON - Last week, shareholders in privately held Adprotech Ltd. agreed to be taken over by Inflazyme Pharmaceuticals Ltd. for about C$20 million (US$14.9 million) in shares. (BioWorld International)Read More
